| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87428 |
|
10,327 |
8,967 |
$1.15M |
| 86328 |
|
9,380 |
8,288 |
$345K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,422 |
1,686 |
$181K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
6,486 |
3,772 |
$169K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13,252 |
11,283 |
$143K |
| 0001A |
|
12 |
12 |
$498.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,286 |
2,428 |
$404.67 |
| 0240U |
|
79 |
70 |
$228.20 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,564 |
1,856 |
$0.00 |
| 99072 |
|
237 |
161 |
$0.00 |